Skip to main content

Table 2 Metachronous SPCs, time to SPCs and locations of the SPCs after LDR-BT

From: Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up

SPCs, organs involvedn%< 5 years≥ 5 yearsOOFIF
All361001323324
Lung616.7246 
Colon513.9235 
Skina513.9325 
Hematologic411.1314 
Bladder25.6 2 2
Rectum12.8 1 1
Prostate (SCC)12.8 1 1
Otherb1233.33912 
  1. SPC Subsequent primary cancer, LDR-BT Low dose-rate brachytherapy, SCC Squamous cell cancer, OOF Out-of-field, IF In-field
  2. aFibrosarcoma, Squamous cell cancer, Melanoma
  3. bHead and neck (n = 3), Liver (n = 2) and one of each: Brain, Eye melanoma, Esophagus, Pancreas, Kidney, Malignant schwannoma (muscle), Sarcoma (hand)